Fulcrum TherapeuticsFULC

那斯達克 · USD
8.25
+0.35
(+4.43%)
收盤 04/16 03:59 (UTC+8)
04/16 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.01
  • 0.01
  • -
  • 0.80
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -13.75
  • 14.76
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
營業收入淨額
-
-
-
-
-
-
80,000
-
871
759
營業成本
----------
營業毛利
-
-
-
-
-
-
80,000
-
871
759
營業費用
22,69321,85819,815-19,42925,12627,50829,83428,86328,199
研發費用
15,41614,29612,98713,40411,71314,63917,26119,77318,99918,238
推銷及管理費用
7,2777,5626,8286,9997,7168,42410,24710,0619,8649,961
非經常性項目費用
-----2,063----
其他營業費用
----------
營業利益
-22,693
-21,858
-19,815
-20,403
-19,429
-25,126
52,492
-29,834
-27,992
-27,440
其他收入及費用
2,3592,2632,5192,7482,8613,4302,9172,9643,2363,423
利息費用
----------
稅前純益
-20,334
-19,595
-17,296
-17,655
-16,568
-21,696
55,409
-26,870
-24,756
-24,017
所得稅
----------
稅後純益
-20,334
-19,595
-17,296
-17,655
-16,568
-21,696
55,409
-26,870
-24,756
-24,017
基本每股稅後盈餘(元)
-0.31-0.31-0.28-0.28-0.31-0.350.89-0.43-0.40-0.39
稀釋每股稅後盈餘(元)
-0.31-0.31-0.28-0.28-0.27-0.340.88-0.43-0.40-0.39
基本平均股數(千股)
65781.0062597.0062544.0062479.0053954.0062409.0062205.0061984.0061871.0061823.00
稀釋平均股數(千股)
65781.0062597.0062544.0062479.0053954.0062409.0063587.0061984.0061871.0061823.00
還原基本每股稅後盈餘(元)
-0.31-0.31-0.28-0.28-0.31-0.350.89-0.43-0.40-0.39
還原稀釋每股稅後盈餘(元)
-0.31-0.31-0.28-0.28-0.27-0.340.88-0.43-0.40-0.39
還原基本平均股數(千股)
65,78162,59762,54462,47953,95462,40962,20561,98461,87161,823
還原稀釋平均股數(千股)
65,78162,59762,54462,47953,95462,40963,58761,98461,87161,823
EBITDA(千元)
-20,370-19,835-18,037-18,201-17,144-22,47954,651-27,552-25,576-25,071

大家都在看

HOT